Consistent with our data, a small proportion of Tregs co-expressed CD103 [27] and the percentage of CD4+CD103+ TILs was much lower than CD8+CD103+ TILs in patients with ovarian and bladder cancers [18, 22]. The gene discussed is CD4; the disease is urinary bladder cancer.